Tringali S, Philippe C, Benchemam Y, Dumollard J-M, Seguin P
Service de Stomatologie et de Chirurgie Maxillo-faciale, CHU Bellevue, 42055 Saint-Etienne Cedex 02.
Rev Stomatol Chir Maxillofac. 2005 Apr;106(2):99-102. doi: 10.1016/s0035-1768(05)85818-8.
The combination of a malignant peripheral nerve sheath tumor with rhabdomyosarcomatous elements has been termed Malignant Triton Tumor (MTT). This tumor was first reported in 1932 and the prognosis was poor. Involvement of the sinonasal tract is rare with only 10 case reports.
We report the case of a 80-year-old woman who presented an obstruction of the right nasal fossa which developed over several years without anosmia. She consulted because of recurrent epistaxis. The CT-scan revealed a tumor occupying the right ethmoid the right maxillary sinus and the homolateral nasal fossa. Resection was achieved via an extended mediofacial route. The histological diagnosis was low-grade schwannosarcoma with a discretely extended rhabdomyosarcomatous component, i.e. MTT. No complementary treatment was given. Eight months later, the tumor relapsed with cerebral involvement. Despite new surgery with two teams, a neurosurgical and a radiotherapy team, the tumor relapsed at the ethmoid-nasal level. After five years, the patient is alive with local progression without metastasis.
MTT of the sinonasal tract is a rare disease that clinicians should be aware of and that must be included in the differential diagnosis of malignant lesions involving the sinonasal tract. Most of the reported cases involving localizations other than the ethmoidonasal cavities, are associated with von Recklinhausen neurofibromatosis and occurr in young subjects (mean age 35 years). There have however been sporadic cases, mainly in older women or after radiotherapy. The prognosis is somewhat better for ethmoidonasal localizations.
恶性外周神经鞘瘤合并横纹肌肉瘤成分被称为恶性蝾螈瘤(MTT)。该肿瘤于1932年首次报道,预后较差。鼻窦道受累罕见,仅有10例病例报告。
我们报告一例80岁女性患者,其右侧鼻窝阻塞数年,无嗅觉减退。因反复鼻出血就诊。CT扫描显示肿瘤占据右侧筛窦、右侧上颌窦及同侧鼻窝。通过扩大的面中入路进行切除。组织学诊断为低级别神经鞘肉瘤,伴有散在的横纹肌肉瘤成分,即MTT。未给予辅助治疗。8个月后,肿瘤复发并累及脑部。尽管由神经外科和放疗团队进行了新的手术,但肿瘤仍在筛窦-鼻腔水平复发。5年后,患者存活,有局部进展但无转移。
鼻窦道MTT是一种罕见疾病,临床医生应予以关注,且必须纳入鼻窦道恶性病变的鉴别诊断。大多数报道的非筛窦鼻腔定位病例与冯雷克林霍增氏神经纤维瘤病相关,且发生于年轻患者(平均年龄35岁)。然而也有散发病例,主要见于老年女性或放疗后。筛窦鼻腔定位的预后稍好一些。